Molecular-Guided Therapy for Relapsed and Refractory Childhood Cancer
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Brain Tumors
- Medulloblastoma
- Neuroblastoma
- Rare Tumors
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 13 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT01802567
- Collaborators
- Dell, Inc.
- Investigators
- Study Chair: Giselle Sholler, MD Beat Childhood Cancer at Atrium Health
Get Well Soon